BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38270925)

  • 1. Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci.
    Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
    Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
    World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
    Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Kuma S; Kuma K; Futami H; Yamaguchi K
    World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M; Miyauchi A; Yoshioka K; Oda H; Nakayama A; Sasai H; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Ito Y; Kobayashi K; Miya A
    Auris Nasus Larynx; 2016 Oct; 43(5):551-5. PubMed ID: 26837867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.
    Essig GF; Porter K; Schneider D; Arpaia D; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas LH; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT
    Thyroid; 2016 Nov; 26(11):1563-1572. PubMed ID: 27604949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical strategy for the treatment of medullary thyroid carcinoma.
    Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
    Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
    Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
    Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
    Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
    Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
    Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
    Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
    Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
    Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 18. Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.
    Zhang D; Colombo C; Sun H; Kim HY; Pino A; De Leo S; Gazzano G; Persani L; Dionigi G; Fugazzola L
    Front Endocrinol (Lausanne); 2022; 13():875875. PubMed ID: 35898450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroidectomy Outcomes in Patients Identified With RET Pathogenic Variants Through a Population Genomic Screening Program.
    Pichardo PFA; Hellums RN; Hao J; Savatt JM; Hassen D; Pellitteri PK; Alvi M; Buchanan AH; Purdy NC
    JAMA Otolaryngol Head Neck Surg; 2023 Mar; 149(3):195-202. PubMed ID: 36602781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.